# Effect of NMN (Nicotinamide Mononucleotide) on Diminished Ovarian Reserve (Including Premature Ovarian Insufficiency)

> **NCT05485610** · NA · UNKNOWN · sponsor: **Peking University Third Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Diminished Ovarian Reserve
- Premature Ovarian Insufficiency

## Interventions

- **DIETARY_SUPPLEMENT:** NMN intervention
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05485610
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05485610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05485610, "Effect of NMN (Nicotinamide Mononucleotide) on Diminished Ovarian Reserve (Including Premature Ovarian Insufficiency)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05485610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*